Referenser

  1. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-10.

  2. Brink M, Cronqvist J, Fagerberg A, Lindgren P, Lipcsey M, Okas M, et al. Nu gäller Sepsis-3 för definitioner och diagnostiska kriterier. Lakartidningen. 2018;115.

  3. Svensk barninfektionsläkarförening. Nationellt vårdprogram för initial handläggning av misstänkt sepsis hos barn 2023 [Available from: https://inf.barnlakarforeningen.se/wp-content/uploads/sites/22/2023/05/Pediatrisk-sepsis-Svenska-riktlinjer-2023-04-27.pdf

  4. Mellhammar L, Wollter E, Dahlberg J, Donovan B, Olséen CJ, Wiking PO, et al. Estimating Sepsis Incidence Using Administrative Data and Clinical Medical Record Review. JAMA network open. 2023;6(8):e2331168.

  5. Mellhammar L, Wullt S, Lindberg A, Lanbeck P, Christensson B, Linder A. Sepsis Incidence: A Population-Based Study. Open Forum Infect Dis. 2016;3(4):ofw207.

  6. Ljungstrom L, Andersson R, Jacobsson G. Incidences of community onset severe sepsis, Sepsis-3 sepsis, and bacteremia in Sweden - A prospective population-based study. PLoS One. 2019;14(12):e0225700.

  7. Strandberg G, Walther S, Ohman CA, Lipcsey M. Mortality after Severe Sepsis and Septic Shock in Swedish Intensive Care Units 2008-2016-A nationwide observational study. Acta anaesthesiologica Scandinavica. 2020;64(7):967-75.

  8. Weiss SL, Fitzgerald JC, Pappachan J, Wheeler D, Jaramillo-Bustamante JC, Salloo A, et al. Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med. 2015;191(10):1147-57.

  9. Rhee C, Dantes R, Epstein L, et al. Incidence and trends of sepsis in us hospitals using clinical vs claims data, 2009-2014. JAMA. 2017;318(13):1241-9.

  10. Henriksen DP, Laursen CB, Jensen TG, Hallas J, Pedersen C, Lassen AT. Incidence rate of community-acquired sepsis among hospitalized acute medical patients-a population-based survey. Crit Care Med. 2015;43(1):13-21.

  11. Hartman ME, Linde-Zwirble WT, Angus DC, Watson RS. Trends in the epidemiology of pediatric severe sepsis*. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 2013;14(7):686-93.

  12. Opal SM, Laterre PF, Francois B, LaRosa SP, Angus DC, Mira JP, et al. Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA. 2013;309(11):1154-62.

  13. Plunkett A, Tong J. Sepsis in children. BMJ (Clinical research ed). 2015;350:h3017.

  14. Beale R, Reinhart K, Brunkhorst FM, Dobb G, Levy M, Martin G, et al. Promoting Global Research Excellence in Severe Sepsis (PROGRESS): lessons from an international sepsis registry. Infection. 2009;37(3):222-32.

  15. Agyeman PKA, Schlapbach LJ, Giannoni E, Stocker M, Posfay-Barbe KM, Heininger U, et al. Epidemiology of blood culture-proven bacterial sepsis in children in Switzerland: a population-based cohort study. Lancet Child Adolesc Health. 2017;1(2):124-33.

  16. Liu VX, Fielding-Singh V, Greene JD, Baker JM, Iwashyna TJ, Bhattacharya J, et al. The Timing of Early Antibiotics and Hospital Mortality in Sepsis. Am J Respir Crit Care Med. 2017;196(7):856-63.

  17. Holmbom M, Andersson M, Berg S, Eklund D, Sobczynski P, Wilhelms D, et al. Prehospital delay is an important risk factor for mortality in community-acquired bloodstream infection (CA-BSI): a matched case-control study. BMJ open. 2021;11(11):e052582.

  18. Gotmaker R, Peake SL, Forbes A, Bellomo R. Mortality is Greater in Septic Patients With Hyperlactatemia Than With Refractory Hypotension. Shock. 2017;48(3):294-300.

  19. Chen H, Zhao C, Wei Y, Jin J. Early lactate measurement is associated with better outcomes in septic patients with an elevated serum lactate level. Crit Care. 2019;23(1):351.

  20. Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med. 2021;49(11):e1063-e143.

  21. Weiss SL, Peters MJ, Alhazzani W, Agus MSD, Flori HR, Inwald DP, et al. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Intensive Care Med. 2020;46(Suppl 1):10-67.

  22. Svenska infektionsläkarföreningen. Nationellt vårdprogram för sepsis och septisk chock 2022 [Available from: https://infektion.net/wp-content/uploads/2022/07/vardprogram_sepsis_maj-2023.pdf

  23. van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004;351(18):1849-59.

  24. Glimåker M, Johansson B, Bell M, Ericsson M, Bläckberg J, Brink M, et al. Early lumbar puncture in adult bacterial meningitis--rationale for revised guidelines. Scand J Infect Dis. 2013;45(9):657-63.

  25. de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002;347(20):1549-56.

  26. Tunkel AR, Glaser CA, Bloch KC, Sejvar JJ, Marra CM, Roos KL, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008;47(3):303-27.

  27. Glimåker M, Johansson B, Halldorsdottir H, Wanecek M, Elmi-Terander A, Ghatan PH, et al. Neuro-intensive treatment targeting intracranial hypertension improves outcome in severe bacterial meningitis: an intervention-control study. PLoS One. 2014;9(3):e91976.

  28. Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis. 2014;59(2):147-59.

  29. Information från Läkemedelsverket. Läkemedelsbehandling av bakteriella hud- och mjukdelsinfektioner i öppenvård – behandlingsrekommendation.; 2018.

  30. Darenberg J, Ihendyane N, Sjolin J, Aufwerber E, Haidl S, Follin P, et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2003;37(3):333-40.

  31. Brink M, Arnell P, Lycke H, Rosemar A, Hagberg L. A series of severe necrotising soft-tissue infections in a regional centre in Sweden. Acta anaesthesiologica Scandinavica. 2014;58(7):882-90.

Föregående sida
För vidare läsning

Nästa sida
Tillbaka till kapitlets första sida